LYFE Capital and Advantage Partners Launch Tender Offer for Nihon Chouzai
LYFE Capital and Advantage Partners Initiate Tender Offer for Nihon Chouzai
On July 31, 2025, LYFE Capital announced the commencement of a public tender offer for Nihon Chouzai Co., Ltd., a prominent healthcare group in Japan, which operates businesses in pharmacy services, pharmaceutical manufacturing, and healthcare staffing and consulting. The move is in partnership with Advantage Partners, marking a significant milestone in the healthcare investment sector in Japan.
The board of directors at Nihon Chouzai has expressed its support for the tender offer, encouraging its shareholders to participate. This tender offer is facilitated through AP86, a company backed by funds from LYFE Capital and Advantage Partners.
Nihon Chouzai, established in 1980, has committed itself to addressing the health needs of all individuals with its mission of
Topics General Business）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.